Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pediatr Surg ; 40(8): 1252-7, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16080928

RESUMO

BACKGROUND: Hepatic fibrosis and cirrhosis develop progressively in extrahepatic biliary atresia (EHBA) despite timely surgical intervention. PURPOSE: The aim of the study was to define CD4+ helper T lymphocytes, cytotoxic CD8+ T lymphocytes, and CD68+ (macrophages) infiltration of portal tracts and lobules and hepatic fibrosis as possible predictive measures of outcome of infants having EHBA. METHODS: The outcome of 32 infants with EHBA was correlated to their percutaneous biopsy and postportoenterostomy core liver tissue infiltration by CD4+, CD68+, and CD8+ cells and to the degree of detected fibrosis. RESULTS: Portoenterostomy cores were heavily infiltrated by CD4+, CD8+, and CD68+, compared with the preoperative liver biopsy (P = .008, .004, and .017, respectively). Infants having favorable outcome had more macrophage infiltration in portoenterostomy core compared with those having an unfavorable outcome (25.66 +/- 29.77 per HPF compared with 11.62 +/- 4.58, P = .000). Mean CD4+/CD8+ ratio was 1.54 +/- 1.37 in those who died within 18 months postoperatively and 0.733 +/- 0.48 in others (P = .021). CONCLUSION: Immune-mediated destruction of portal tracts is an integral part of pathogenesis of EHBA.


Assuntos
Ductos Biliares Extra-Hepáticos/imunologia , Atresia Biliar/complicações , Atresia Biliar/imunologia , Cirrose Hepática Biliar/imunologia , Análise de Variância , Antígenos CD/análise , Antígenos CD/imunologia , Antígenos de Diferenciação Mielomonocítica/análise , Antígenos de Diferenciação Mielomonocítica/imunologia , Ductos Biliares Extra-Hepáticos/patologia , Atresia Biliar/cirurgia , Antígenos CD4/análise , Antígenos CD8/análise , Feminino , Humanos , Imuno-Histoquímica , Lactente , Recém-Nascido , Fígado/imunologia , Fígado/patologia , Cirrose Hepática Biliar/etiologia , Cirrose Hepática Biliar/patologia , Contagem de Linfócitos , Macrófagos/imunologia , Masculino , Sistema Porta/imunologia , Sistema Porta/patologia , Portoenterostomia Hepática , Prognóstico , Estatísticas não Paramétricas , Linfócitos T Citotóxicos/imunologia , Linfócitos T Auxiliares-Indutores/imunologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA